Skip to main content

Want a detailed portfolio tracker?

Protara Therapeutics (TARA) P/E (2019 - 2026)

Protara Therapeutics (TARA) P/E from Dec 31, 2019 to Jul 21, 2026. The TTM Protara Therapeutics (TARA) P/E is -2.97. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Protara Therapeutics (TARA)

YearP/EChange
2026-2.97-24.06%
2025-3.91+101.06%
2024-1.94+535.17%
2023-0.31-62.22%
2022-0.81-49.50%
2021-1.60-70.26%
2020-5.40-68.45%
2019-17.10N/A

Comparison Protara Therapeutics (TARA) P/E with competitors

Protara Therapeutics (TARA) P/E is -2.97.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.14%
ENLVEnlivex Ltd0.07-102.52%
FGENFibroGen Inc0.24-108.08%
CHRSCoherus Biosciences Inc0.85-128.57%
FBIOFortress Biotech Inc0.95-131.96%
ORMPOramed Pharmaceuticals Inc1.50-150.62%
AGENAgenus Inc3.01-201.35%
INVAInnoviva Inc3.15-206.21%
VXRTVaxart Inc3.55-219.54%
CRMDCorMedix Inc3.63-222.19%
CVACCureVac N.V.4.45-249.71%
GLPGGalapagos NV4.86-263.62%
SRPTSarepta Therapeutics Inc4.88-264.40%
ABEOAbeona Therapeutics Inc5.39-281.42%
ABUSArbutus Biopharma Corp5.60-288.43%
ZVRAZevra Therapeutics Inc5.89-298.25%
SPROSpero Therapeutics Inc6.23-309.74%
CGENCompugen Ltd6.31-312.62%
RIGLRigel Pharmaceuticals6.87-331.42%
SLXNSilexion Therapeutics Corp7.30-345.69%
OMEROmeros Corporation9.26-411.79%
AUPHAurinia Pharmaceuticals Inc9.58-422.77%
PLXProtalix BioTherapeutics Inc10.89-466.75%
ACADAcadia Pharmaceuticals Inc11.73-494.96%
ADMAAdma Biologics Inc12.42-518.18%
HRMYHarmony Biosciences Holdings Inc13.82-565.39%
SABSSAB Biotherapeutics Inc14.14-576.04%
NAGENiagen Bioscience Inc14.82-599.00%
INCYIncyte Corp15.82-632.82%
REGNRegeneron Pharmaceuticals Inc15.86-633.97%
PBYIPuma Biotechnology Inc17.32-683.11%
CPRXCatalyst Pharmaceuticals Inc17.44-687.27%
EXELExelixis Inc17.54-690.59%
TGTXTG Therapeutics Inc18.97-738.68%
MDXGMimedx Group Inc20.55-792.11%
XOMAXOMA Royalty Corp22.87-870.33%
ARGXArgen X SE24.30-918.26%
CTMXCytomX Therapeutics Inc24.82-935.87%
XOMAOXOMA Royalty Corp25.34-953.51%
HALOHalozyme Therapeutics Inc25.62-962.90%
XOMAPXOMA Royalty Corp25.67-964.46%
VRTXVertex Pharmaceuticals Inc27.99-1042.75%
RPRXRoyalty Pharma plc - Class A28.69-1066.08%
SLNOSoleno Therapeutics Inc29.02-1077.12%
ASNDAscendis Pharma A/S30.09-1113.16%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1376.72%
APLSApellis Pharmaceuticals Inc39.02-1414.07%
BMRNBiomarin Pharmaceutical Inc42.21-1521.52%
KRYSKrystal Biotech Inc45.34-1626.98%
ONCBeiGene Ltd69.54-2441.84%
PHARPharming Group N.V.75.03-2626.55%
TECHBio-Techne Corp101.96-3533.54%
VCELVericel Corp109.92-3801.70%
ALNYAlnylam Pharmaceuticals Inc117.96-4072.58%
GMABGenmab140.29-4824.42%
TLXTelix Pharmaceuticals Ltd162.15-5560.64%
CORTCorcept Therapeutics Inc212.86-7268.17%